XNCR Competitors & Alternatives

Compare Xencor Inc with similar stocks in the same industry

Biotechnology

XNCR

Main Stock
$35.61
-3.99%
Tradestie Score
30
Market Cap
$843.75M
Revenue Growth
454.9%
Analyst Upside
+19.3%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: XmAb Fc domain engineering, bispecific antibody platforms, cytokine engineering
Major Customers 5
Novartis Amgen Astellas Janssen MorphoSys
Critical Suppliers 5
contract research organizations biomanufacturing CMOs reagent suppliers clinical trial sites antibody production partners
Direct Ecosystem Rivals 4

Top Competitors

216 stocks in Biotechnology
Company Price Market Cap P/E Score Action
SLNO Soleno Therapeutics, Inc. Common Stock
$53.01
+0.04%
$3.20B 27.5 48 Compare
MLYS Mineralys Therapeutics, Inc. Common Stock
$14.74
-3.85%
$3.09B - 59 Compare
VKTX Viking Therapeutics, Inc
$26.86
-8.08%
$3.08B - 39 Compare
CNTA Centessa Pharmaceuticals plc American Depositary Shares
$40.50
+0.80%
$3.03B - 48 Compare
XENE Xenon Pharmaceuticals Inc
$39.31
-2.90%
$3.02B - 33 Compare
CGON CG Oncology, Inc. Common stock
$84.94
+14.16%
$3.01B - 34 Compare
APLS Apellis Pharmaceuticals, Inc. Common Stock
$41.03
-0.07%
$2.92B 38.3 50 Compare
RARE Ultragenyx Pharmaceutical Inc.
$15.96
-0.78%
$2.89B - 42 Compare
IMVT Immunovant, Inc. Common Stock
$33.31
-2.56%
$2.85B - 34 Compare
CPRX Catalyst Pharmaceutical Inc.
$31.49
+0.03%
$2.56B 18.2 51 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

216 stocks in this industry